Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Traws Pharma Inc.

    NASDAQ: TRAW · Real-Time Price · USD
    1.67
    0.04 (2.45%)
    At close: Jun 17, 2025, 3:27 PM

    Traws Pharma Statistics

    Share Statistics

    Traws Pharma has 5.56M shares outstanding. The number of shares has increased by -80.11% in one year.

    Shares Outstanding

    n/a
    		 5.56M

    Shares Change (YoY)

    n/a
    		 -80.11%

    Shares Change (QoQ)

    n/a
    		 66.36%

    Owned by Institutions (%)

    n/a
    		 4.62%

    Shares Floating

    n/a
    		 4.52M

    Failed to Deliver (FTD) Shares

    n/a
    		 454

    FTD / Avg. Volume

    n/a
    		 0.04%

    Short Selling Information

    The latest short interest is 95.72K, so 1.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 95.72K

    Short % of Shares Out

    n/a
    		 1.72%

    Short % of Float

    n/a
    		 2.56%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.35 and the forward PE ratio is -0.09. Traws Pharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.35

    Forward PE

    n/a
    		 -0.09

    PS Ratio

    n/a
    		 994.51

    Forward PS

    n/a
    		 23

    PB Ratio

    n/a
    		 -7.11

    P/FCF Ratio

    n/a
    		 -7.54

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Traws Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 2.16

    Quick Ratio

    n/a
    		 2.16

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $37,666.67

    Profits Per Employee

    n/a
    		 $-27,753,833.33

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -87.34% in the last 52 weeks. The beta is 1.47, so Traws Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.47

    52-Week Price Change

    n/a
    		 -87.34%

    50-Day Moving Average

    n/a
    		 1.57

    200-Day Moving Average

    n/a
    		 4.69

    Relative Strength Index (RSI)

    n/a
    		 51.02

    Average Volume (20 Days)

    n/a
    		 1,152,206

    Income Statement

    In the last 12 months, Traws Pharma had revenue of 226K and earned -166.52M in profits. Earnings per share was -6.58.

    Revenue

    n/a
    		 226K

    Gross Profit

    n/a
    		 214K

    Operating Income

    n/a
    		 -142.37M

    Net Income

    n/a
    		 -166.52M

    EBITDA

    n/a
    		 -24.9M

    EBIT

    n/a
    		 -24.91M

    Earnings Per Share (EPS)

    n/a
    		 -6.58
    Full Income Statement

    Balance Sheet

    The company has 21.34M in cash and 0 in debt, giving a net cash position of 21.34M.

    Cash & Cash Equivalents

    n/a
    		 21.34M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -649.15M

    Total Assets

    n/a
    		 24.96M

    Working Capital

    n/a
    		 13.42M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.79M and capital expenditures 0, giving a free cash flow of -29.79M.

    Operating Cash Flow

    n/a
    		 -29.79M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -29.79M

    FCF Per Share

    n/a
    		 -1.18
    Full Cash Flow Statement

    Margins

    Gross margin is 94.69%, with operating and profit margins of -62997.35% and -73682.74%.

    Gross Margin

    n/a
    		 94.69%

    Operating Margin

    n/a
    		 -62997.35%

    Pretax Margin

    n/a
    		 -73682.74%

    Profit Margin

    n/a
    		 -73682.74%

    EBITDA Margin

    n/a
    		 -11016.81%

    EBIT Margin

    n/a
    		 -62997.35%

    FCF Margin

    n/a
    		 -13182.3%

    Dividends & Yields

    TRAW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TRAW.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 23, 2024. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Sep 23, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -38.96

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist